A new dementia care imperative
In the field of aging services today, a confluence of factors is creating an imperative to move the needle toward more forward-thinking dementia care.
Alzheimer’s
Alzheimer’s vaccine shows promise in study
A vaccine developed by University of New Mexico researchers has shown promise in preventing the formation of the tau tangles in the brain and someday potentially could prevent the cognitive decline typically seen in people with Alzheimer’s disease, they said.
Virtual reality helps diagnose Alzheimer’s disease earlier, study finds
Virtual reality can identify early Alzheimer’s disease more accurately than cognitive tests currently considered to be the “gold standard,” suggests a new study published in the journal Brain.
Is Alzheimer’s research about to go down a new path?
By finding ways to prevent connection losses, the disease progression potentially could be delayed or even reversed, experts said.
Blood test could track whether Alzheimer’s drugs are working
A simple blood test might reveal whether medications being used to treat Alzheimer’s disease are actually working, scientists have found.
Atrium Health announces merger plans with Wake Forest Baptist Health, Wake Forest University
Atrium Health, Wake Forest Baptist Health and Wake Forest University announced plans to merge on Wednesday in an effort to “create a next-generation academic healthcare system” that would include long-term care facilities and research in Alzheimer’s disease and other age-related areas.
Blood tests and phone apps: The future of diagnosing Alzheimer’s?
Last week in a blog post, Bill Gates shared some exciting ways that Alzheimer’s disease might be diagnosed in the future.
Bill would aid those with younger-onset Alzheimer’s disease
Bipartisan legislation that would amend the Older Americans Act to allow individuals aged less than 60 years who have a diagnosis of younger-onset Alzheimer’s disease to access the support programs of the act was featured Tuesday at a hearing of the Senate Special Committee on Aging.
Two Alzheimer’s drug trials halted
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.
How to scale memories, build community and enhance quality of life through 3-D stories
Preliminary results of studies on the effectiveness of 3-D presentations at senior living communities in the United States and Canada are promising.
Next post in Marketplace Columns
